SEC Form 4 · accession 0001209191-16-153878
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Dec 6, 2016
Accepted (ET)
Dec 7, 2016 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2016 | G | 1,000 | $0.00 | D | 32,748 | D | |
| Common Stock | Dec 6, 2016 | M | 7,100 | $1.13 | A | 39,848 | D | |
| Common Stock | Dec 6, 2016 | F | 897 | $8.94 | D | 38,951 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.13 | Dec 6, 2016 | M | 7,100 | D | — | Dec 11, 2017 | Common Stock | 7,100 | 2,098 | D |
Explanation of responses
- F1This option is fully vested.